TYK2 INHIBITORS AND USES THEREOF

(19)

(11)

EP 3 344 624 B8

(12)	CORRECTED EUROPEAN PATENT SPECIFICATION
	Note: Bibliography reflects the latest situation

(15)	Correction information:
	Corrected version no 1 (W1 B1)

(48)	Corrigendum issued on:
	29.11.2023 Bulletin 2023/48

(45)	Mention of the grant of the patent:
	25.10.2023 Bulletin 2023/43

(21)	Application number: 16842967.8

(22)	Date of filing: 01.09.2016

(51)

International Patent Classification (IPC):

C07D 471/04^(2006.01)
A61P 35/00^(2006.01)
A61K 31/437^(2006.01)

C07D 487/04^(2006.01)
A61P 37/00^(2006.01)

(52)	Cooperative Patent Classification (CPC):
	A61P 35/00; A61P 37/00; C07D 471/04; C07D 519/00

	C-Sets:
	C07D 471/04, C07B 2200/05;

(86)	International application number:
	PCT/US2016/049852

(87)	International publication number:
	WO 2017/040757 (09.03.2017 Gazette 2017/10)

(54)	TYK2 INHIBITORS AND USES THEREOF TYK2-INHIBITOREN UND VERWENDUNGEN DAVON INHIBITEURS DE TYK2 ET LEURS UTILISATIONS

(84)	Designated Contracting States:
	AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30)

Priority:

02.09.2015 US 201562213475 P
03.09.2015 US 201562214018 P

(43)	Date of publication of application:
	11.07.2018 Bulletin 2018/28

(60)	Divisional application:
	23205337.1

(73)	Proprietor: Takeda Pharmaceutical Company Limited
	Osaka 540-8645 (JP)

(72)

Inventors:

MASSE, Craig E.
Cambridge, Massachusetts 02139 (US)
GREENWOOD, Jeremy Robert
Brooklyn, New York 11238 (US)
ROMERO, Donna L.
Chesterfield, Missouri 63005 (US)
HARRIMAN, Geraldine C.
Charlestown, Rhode Island 02813 (US)
WESTER, Ronald T.
Ledyard, Connecticut 06339 (US)
SHELLEY, Mee
Tigard, Oregon 97223 (US)
KENNEDY-SMITH, Joshua Jahmil
New York, New York 10014 (US)
DAHLGREN, Markus
Stratford, Connecticut 06615 (US)
MONDAL, Sayan
New York, New York 10044 (US)

(74)	Representative: Carpmaels & Ransford LLP
	One Southampton Row London WC1B 5HA London WC1B 5HA (GB)

(56)

References cited: :

EP-A1- 2 108 642
WO-A1-2016/138352
US-A1- 2011 082 136

WO-A1-2011/079051
US-A1- 2010 210 623
US-A1- 2015 266 875

Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).